rs2941503
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033419.5(PGAP3):c.*311T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.665 in 431,570 control chromosomes in the GnomAD database, including 97,390 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.64 ( 31436 hom., cov: 32)
Exomes 𝑓: 0.68 ( 65954 hom. )
Consequence
PGAP3
NM_033419.5 3_prime_UTR
NM_033419.5 3_prime_UTR
Scores
8
Clinical Significance
Conservation
PhyloP100: -0.128
Publications
39 publications found
Genes affected
PGAP3 (HGNC:23719): (post-GPI attachment to proteins phospholipase 3) This gene encodes a glycosylphosphatidylinositol (GPI)-specific phospholipase that primarily localizes to the Golgi apparatus. This ubiquitously expressed gene is predicted to encode a seven-transmembrane protein that removes unsaturated fatty acids from the sn-2 position of GPI. The remodeling of the constituent fatty acids on GPI is thought to be important for the proper association between GPI-anchored proteins and lipid rafts. The tethering of proteins to plasma membranes via posttranslational GPI-anchoring is thought to play a role in protein sorting and trafficking. Mutations in this gene cause an autosomal recessive form of neurologic hyperphosphatasia with cognitive disability (HPMRS4). Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
PGAP3 Gene-Disease associations (from GenCC):
- hyperphosphatasia with intellectual disability syndrome 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- hyperphosphatasia-intellectual disability syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.003986627).
BP6
Variant 17-39672492-A-G is Benign according to our data. Variant chr17-39672492-A-G is described in ClinVar as [Benign]. Clinvar id is 1232753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.717 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.637 AC: 96831AN: 151924Hom.: 31411 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
96831
AN:
151924
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.681 AC: 190224AN: 279528Hom.: 65954 Cov.: 0 AF XY: 0.688 AC XY: 101785AN XY: 147992 show subpopulations
GnomAD4 exome
AF:
AC:
190224
AN:
279528
Hom.:
Cov.:
0
AF XY:
AC XY:
101785
AN XY:
147992
show subpopulations
African (AFR)
AF:
AC:
4536
AN:
8416
American (AMR)
AF:
AC:
6526
AN:
11064
Ashkenazi Jewish (ASJ)
AF:
AC:
5953
AN:
8506
East Asian (EAS)
AF:
AC:
7852
AN:
17520
South Asian (SAS)
AF:
AC:
25913
AN:
33712
European-Finnish (FIN)
AF:
AC:
11035
AN:
15598
Middle Eastern (MID)
AF:
AC:
947
AN:
1226
European-Non Finnish (NFE)
AF:
AC:
116680
AN:
167346
Other (OTH)
AF:
AC:
10782
AN:
16140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2763
5526
8289
11052
13815
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.637 AC: 96915AN: 152042Hom.: 31436 Cov.: 32 AF XY: 0.636 AC XY: 47279AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
96915
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
47279
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
22883
AN:
41444
American (AMR)
AF:
AC:
8974
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
2420
AN:
3468
East Asian (EAS)
AF:
AC:
2115
AN:
5156
South Asian (SAS)
AF:
AC:
3555
AN:
4824
European-Finnish (FIN)
AF:
AC:
7631
AN:
10598
Middle Eastern (MID)
AF:
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47060
AN:
67956
Other (OTH)
AF:
AC:
1336
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1791
3581
5372
7162
8953
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2562
ALSPAC
AF:
AC:
2661
Asia WGS
AF:
AC:
2145
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
MetaRNN
Benign
T
PhyloP100
Sift4G
Benign
T
Vest4
MVP
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.